OTLK · Insider Trading
Outlook Therapeutics, Inc. Common Stock
Every open-market purchase and sale reported by OTLK officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-02 | Kevin Michael Lundquist | Chief Financial Officer | A | +500,000 deriv. | — |
| 2026-08-14 | Lawrence A Kenyon | Chief Financial Officer | Buy | +101,010 | — |
| 2026-08-14 | Robert Charles Jahr | Chief Executive Officer | Buy | +151,515 | — |
| 2026-08-14 | Ghiath M. Sukhtian | Director | Buy | +5,050,504 | +$5.00M |
| 2026-07-29 | Faisal Ghiath Sukhtian | Director | Buy | +95,398 | +$100.00K |
| 2026-07-23 | Robert Charles Jahr | Chief Executive Officer | A | +100,000 deriv. | — |
| 2026-07-23 | Lawrence A Kenyon | Chief Financial Officer | A | +210,078 deriv. | — |
| 2026-06-03 | Yezan Munther Haddadin | Director | Buy | +29,000 | +$24.15K |
| 2026-06-01 | GMS Ventures & Investments | Director | Buy | +17,079,418 | +$10.00M |
| 2026-05-27 | Randy H Thurman | Director | Buy | +5,000 | +$2.15K |
| 2026-05-27 | Yezan Munther Haddadin | Director | Buy | +34,000 | +$14.96K |
| 2026-05-27 | Faisal Ghiath Sukhtian | Director | Buy | +122,174 | +$50.01K |
| 2026-05-27 | Kurt J Hilzinger | Director | Buy | +400,000 | +$176.52K |
| 2025-10-03 | Julian S Gangolli | Director | A | +286,734 deriv. | — |
| 2025-10-03 | Andong Huang | Director | A | +340,050 deriv. | — |
| 2025-10-03 | Gerd Auffarth | Director | A | +345,382 deriv. | — |
| 2025-10-03 | Faisal Ghiath Sukhtian | Director | A | +404,030 deriv. | — |
| 2025-10-03 | Julia A Haller | Director | A | +345,382 deriv. | — |
| 2025-10-03 | Kurt J Hilzinger | Director | A | +377,372 deriv. | — |
| 2025-10-03 | Randy H Thurman | Director | A | +286,734 deriv. | — |
| 2025-10-03 | Yezan Munther Haddadin | Director | A | +382,703 deriv. | — |
| 2025-07-09 | Robert Charles Jahr | Chief Executive Officer | A | +800,000 deriv. | — |
| 2025-05-28 | Ghiath M. Sukhtian | Director | A | +8,571,428 | +$12.00M |
| 2025-03-12 | GMS Ventures & Investments | Director | M | +6,917,142 | +$17.36M |
| 2025-02-06 | Faisal Ghiath Sukhtian | Director | A | +12,323 deriv. | — |
| 2025-01-22 | GMS Ventures & Investments | Director | MIXED | +6,917,142 deriv. | — |
| 2024-10-03 | Faisal Ghiath Sukhtian | Director | A | +210,837 deriv. | — |
| 2024-10-03 | Andong Huang | Director | A | +91,129 deriv. | — |
| 2024-10-03 | Gerd Auffarth | Director | A | +98,211 deriv. | — |
| 2024-10-03 | Julia A Haller | Director | A | +115,950 deriv. | — |
| 2024-10-03 | Kurt J Hilzinger | Director | A | +180,459 deriv. | — |
| 2024-10-03 | Yezan Munther Haddadin | Director | A | +208,700 deriv. | — |
| 2024-10-03 | Julian S Gangolli | Director | A | +127,805 deriv. | — |
| 2024-10-03 | Randy H Thurman | Director | A | +146,185 deriv. | — |
| 2024-09-30 | Lawrence A Kenyon | Chief Financial Officer | Buy | +5,000 | +$28.45K |
| 2024-04-17 | Syntone Ventures LLC | 10%+ Owner | Buy | +714,286 | — |
| 2024-03-29 | Yezan Munther Haddadin | Director | Buy | +1,881 | +$22.24K |
| 2024-03-22 | C Russell Trenary III | CEO AND PRESIDENT | A | +455,000 deriv. | — |
| 2024-03-22 | Jeff Evanson | CHIEF COMMERCIAL OFFICER | A | +25,000 deriv. | — |
| 2024-03-22 | Lawrence A Kenyon | CHIEF FINANCIAL OFFICER | A | +12,500 deriv. | — |
| 2024-03-20 | GMS Ventures & Investments | Director | A | +4,611,428 | — |
| 2024-03-11 | Jeff Evanson | CHIEF COMMERCIAL OFFICER | Buy | +62,484 | +$26.24K |
| 2024-03-08 | Faisal Ghiath Sukhtian | Director | A | +94,441 deriv. | — |
| 2024-03-08 | Randy H Thurman | Director | A | +94,441 deriv. | — |
| 2024-03-08 | Gerd Auffarth | Director | A | +94,441 deriv. | — |
| 2024-03-08 | Andong Huang | Director | A | +94,441 deriv. | — |
| 2024-03-08 | Julia A Haller | Director | A | +94,441 deriv. | — |
| 2024-03-08 | Kurt J Hilzinger | Director | A | +94,441 deriv. | — |
| 2024-03-08 | Julian S Gangolli | Director | A | +94,441 deriv. | — |
| 2024-03-08 | Yezan Munther Haddadin | Director | A | +94,441 deriv. | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Ghiath M. Sukhtian | Director | 24,617,320 | $14.18M |
| GMS Ventures & Investments | Director | 22,092,068 | $12.73M |
| Kurt J Hilzinger | Director | 423,655 | $244.11K |
| Faisal Ghiath Sukhtian | Director | 220,972 | $127.32K |
| Robert Charles Jahr | Chief Executive Officer | 151,515 | $87.30K |
| Lawrence A Kenyon | Chief Financial Officer | 106,956 | $61.63K |
| Yezan Munther Haddadin | Director | 66,167 | $38.13K |
| Randy H Thurman | Director | 5,593 | $3.22K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the OTLK quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.